Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Central xanthoma of the jaw in association with Noonan syndrome.

Olson NJ, Addante RR, de Abreu FB, Memoli VA.

Hum Pathol. 2018 Dec;82:202-205. doi: 10.1016/j.humpath.2018.04.020. Epub 2018 May 1.

PMID:
29727697
2.

Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes.

Tafe LJ, Pierce KJ, Peterson JD, de Abreu F, Memoli VA, Black CC, Pettus JR, Marotti JD, Gutmann EJ, Liu X, Shirai K, Dragnev KH, Amos CI, Tsongalis GJ.

Neoplasia. 2016 Sep;18(9):577-83. doi: 10.1016/j.neo.2016.07.010.

3.

Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFR.

Myung JH, Roengvoraphoj M, Tam KA, Ma T, Memoli VA, Dmitrovsky E, Freemantle SJ, Hong S.

Anal Chem. 2015 Oct 6;87(19):10096-102. doi: 10.1021/acs.analchem.5b02766. Epub 2015 Sep 10.

4.

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

Tafe LJ, Gorlov IP, de Abreu FB, Lefferts JA, Liu X, Pettus JR, Marotti JD, Bloch KJ, Memoli VA, Suriawinata AA, Dragnev KH, Fadul CE, Schwartz GN, Morgan CR, Holderness BM, Peterson JD, Tsongalis GJ, Miller TW, Chamberlin MD.

Oncologist. 2015 Sep;20(9):1011-8. doi: 10.1634/theoncologist.2015-0097. Epub 2015 Jul 23.

5.
6.

Cell cycle and apoptosis regulatory proteins, proliferative markers, cell signaling molecules, CD209, and decorin immunoreactivity in low-grade myxofibrosarcoma and myxoma.

Cates JM, Memoli VA, Gonzalez RS.

Virchows Arch. 2015 Aug;467(2):211-6. doi: 10.1007/s00428-015-1778-8. Epub 2015 May 5.

PMID:
25940995
7.

CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.

Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, Sekula D, Andrew AS, Wistuba II, Freemantle S, Compton DA, Dmitrovsky E.

Cancer Res. 2015 May 15;75(10):2029-38. doi: 10.1158/0008-5472.CAN-14-1494. Epub 2015 Mar 25.

8.

Small cell neuroendocrine carcinomas of the lung do not harbor high-risk human papillomavirus.

Hartley CP, Steinmetz HB, Memoli VA, Tafe LJ.

Hum Pathol. 2015 Apr;46(4):577-82. doi: 10.1016/j.humpath.2014.12.012. Epub 2015 Jan 9.

PMID:
25661244
9.

Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.

diFlorio-Alexander RM, Marotti JD, Bond JS, Schwab MC, Memoli VA, Wells WA, Poplack SP.

AJR Am J Roentgenol. 2015 Jan;204(1):211-8. doi: 10.2214/AJR.14.12869.

PMID:
25539259
10.

ALK-rearranged adenosquamous lung cancer presenting as squamous cell carcinoma: a potential challenge to histologic type triaging of NSCLC biopsies for molecular studies.

Dragnev KH, Gehr G, Memoli VA, Tafe LJ.

Clin Lung Cancer. 2014 May;15(3):e37-40. doi: 10.1016/j.cllc.2014.01.003. Epub 2014 Jan 18. No abstract available.

PMID:
24524823
11.

All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patched.

Busch AM, Galimberti F, Nehls KE, Roengvoraphoj M, Sekula D, Li B, Guo Y, Direnzo J, Fiering SN, Spinella MJ, Robbins DJ, Memoli VA, Freemantle SJ, Dmitrovsky E.

Cancer Biol Ther. 2014 Apr;15(4):463-72. doi: 10.4161/cbt.27821. Epub 2014 Feb 4.

12.

Adenoid cystic carcinoma of the breast in reduction mammoplasty.

Xue Y, Liu X, Poplack S, Memoli VA.

Breast J. 2012 Nov-Dec;18(6):611-3. doi: 10.1111/tbj.12029. Epub 2012 Oct 19. No abstract available.

PMID:
23078292
13.

Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations.

Galimberti F, Busch AM, Chinyengetere F, Ma T, Sekula D, Memoli VA, Dragnev KH, Liu F, Johnson KC, Guo Y, Freemantle SJ, Andrew AS, Greninger P, Robbins DJ, Settleman J, Benes C, Dmitrovsky E.

Int J Oncol. 2012 Nov;41(5):1751-61. doi: 10.3892/ijo.2012.1599. Epub 2012 Aug 22.

14.

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.

Marotti JD, Schwab MC, McNulty NJ, Rigas JR, DeLong PA, Memoli VA, Tsongalis GJ, Padmanabhan V.

Diagn Cytopathol. 2013 Jan;41(1):15-21. doi: 10.1002/dc.21749. Epub 2011 Jun 16.

PMID:
21681971
15.

Orthopaedic specimen preparation: what pathologists should know and do.

Klein MJ, Memoli VA.

Semin Diagn Pathol. 2011 Feb;28(1):4-12. Review.

PMID:
21675373
16.

High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer.

Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KH.

Lung Cancer. 2011 Dec;74(3):384-91. doi: 10.1016/j.lungcan.2011.04.004. Epub 2011 May 8.

PMID:
21555162
17.

Mucolipidosis type III α/β: the first characterization of this rare disease by autopsy.

Kerr DA, Memoli VA, Cathey SS, Harris BT.

Arch Pathol Lab Med. 2011 Apr;135(4):503-10. doi: 10.1043/2010-0236-CR.1.

18.

Lipoprotein lipase links dietary fat to solid tumor cell proliferation.

Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, Pettus JR, Froehlich HM, Memoli VA, Morganelli PM, Swinnen JV, Timmerman LA, Chaychi L, Fricano CJ, Eisenberg BL, Coleman WB, Kinlaw WB.

Mol Cancer Ther. 2011 Mar;10(3):427-36. doi: 10.1158/1535-7163.MCT-10-0802. Epub 2011 Jan 31.

19.
20.

Native MAG-1 antibody almost destroys human breast cancer xenografts.

North WG, Pang RH, Gao G, Memoli VA, Cole BF.

Breast Cancer Res Treat. 2011 Jun;127(3):631-7. doi: 10.1007/s10549-010-1009-6. Epub 2010 Jul 13.

21.

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E.

J Clin Invest. 2010 Apr;120(4):1298-309. doi: 10.1172/JCI39566. Epub 2010 Mar 8.

22.

NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment.

North WG, Gao G, Jensen A, Memoli VA, Du J.

Clin Pharmacol. 2010;2:31-40. doi: 10.2147/CPAA.S6262. Epub 2010 Apr 1.

23.

Breast cancer expresses functional NMDA receptors.

North WG, Gao G, Memoli VA, Pang RH, Lynch L.

Breast Cancer Res Treat. 2010 Jul;122(2):307-14. doi: 10.1007/s10549-009-0556-1. Epub 2009 Sep 26.

24.

Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.

Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, Robbins DJ, Bentley HA, Tsongalis GJ, Demidenko E, Freemantle SJ, Dmitrovsky E.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4089-94. Epub 2007 Feb 27.

25.

Repression of cyclin D1 as a target for germ cell tumors.

Freemantle SJ, Vaseva AV, Ewings KE, Bee T, Krizan KA, Kelley MR, Hattab EM, Memoli VA, Black CC, Spinella MJ, Dmitrovsky E.

Int J Oncol. 2007 Feb;30(2):333-40.

PMID:
17203214
26.

Frequent requirement of hedgehog signaling in non-small cell lung carcinoma.

Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, Memoli VA, Dmitrovsky E, Robbins DJ.

Oncogene. 2007 Feb 15;26(7):1046-55. Epub 2006 Aug 14.

PMID:
16909105
27.

Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.

Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.

Clin Endocrinol (Oxf). 2005 Dec;63(6):676-82.

PMID:
16343103
28.
29.

Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement.

Longnecker DS, Adsay NV, Fernandez-del Castillo C, Hruban RH, Kasugai T, Klimstra DS, Klöppel G, Lüttges J, Memoli VA, Tosteson TD, Yanagisawa A, Wilentz R, Zamboni G.

Pancreas. 2005 Nov;31(4):344-9.

PMID:
16258368
30.

Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.

Petty WJ, Dragnev KH, Memoli VA, Ma Y, Desai NB, Biddle A, Davis TH, Nugent WC, Memoli N, Hamilton M, Iwata KK, Rigas JR, Dmitrovsky E.

Clin Cancer Res. 2004 Nov 15;10(22):7547-54.

31.

Myocardial involvement in Erdheim-Chester disease.

Loeffler AG, Memoli VA.

Arch Pathol Lab Med. 2004 Jun;128(6):682-5.

PMID:
15163229
32.

A novel Streptococcus organism identified in a case of fulminant endocarditis using 16S rDNA sequencing.

Jobbagy Z, Fabian CB, Memoli VA, Schwartzman JD.

J Mol Diagn. 2004 May;6(2):145-8.

33.

Immunohistochemical evaluation of vasopressin expression in breast fibrocystic disease and ductal carcinoma in situ (DCIS).

North WG, Wells W, Fay MJ, Mathew RS, Donnelly EM, Memoli VA.

Endocr Pathol. 2003 Fall;14(3):257-62.

PMID:
14586071
35.

Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.

Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.

Oncogene. 2002 Jan 3;21(1):108-18.

36.

Bispecific Antibody MDX-210 for Treatment of Advanced Ovarian and Breast Cancer.

Kaufman PA, Wallace PK, Valone FH, Wells WA, Memoli VA, Ernstoff MS.

Methods Mol Med. 2001;39:793-806. doi: 10.1385/1-59259-071-3:793.

PMID:
21340841
37.
38.

Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma.

Zacharski LR, Ornstein DL, Memoli VA, Rousseau SM, Kisiel W.

Thromb Haemost. 1998 Apr;79(4):876-7. No abstract available.

PMID:
9569208
39.

Evaluation of p53 mutation in pancreatic acinar cell carcinomas of humans and transgenic mice.

Terhune PG, Memoli VA, Longnecker DS.

Pancreas. 1998 Jan;16(1):6-12.

PMID:
9436856
40.

Fibrillin-1 in human cartilage: developmental expression and formation of special banded fibers.

Keene DR, Jordan CD, Reinhardt DP, Ridgway CC, Ono RN, Corson GM, Fairhurst M, Sussman MD, Memoli VA, Sakai LY.

J Histochem Cytochem. 1997 Aug;45(8):1069-82.

PMID:
9267468
41.

CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause.

White HD, Crassi KM, Givan AL, Stern JE, Gonzalez JL, Memoli VA, Green WR, Wira CR.

J Immunol. 1997 Mar 15;158(6):3017-27.

PMID:
9058841
42.

Well-differentiated pulmonary neuroendocrine carcinoma metastatic to the endometrium: a case report.

Jordan CD, Andrews SJ, Memoli VA.

Mod Pathol. 1996 Nov;9(11):1066-70.

PMID:
8933517
43.
44.

In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.

Camp BJ, Dyhrman ST, Memoli VA, Mott LA, Barth RJ Jr.

Ann Surg Oncol. 1996 Mar;3(2):176-84.

PMID:
8646519
45.

Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding.

Zacharski LR, Memoli VA, Morain WD, Schlaeppi JM, Rousseau SM.

Thromb Haemost. 1995 May;73(5):793-7.

PMID:
7482405
46.

Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung.

Meehan KR, Zacharski LR, Maurer LH, Howell AL, Memoli VA, Rousseau SM, Hunt JA, Henkin J.

Blood Coagul Fibrinolysis. 1995 Apr;6(2):105-12.

PMID:
7605874
48.

Giant cell tumor of the scaphoid: a case report and review of the literature.

Abdu WA, Murphy JM, Memoli VA.

J Hand Surg Am. 1994 Nov;19(6):1003-5. Review. No abstract available.

PMID:
7876470
49.

Sex hormone receptors in non-small-cell lung cancer in human beings.

Canver CC, Memoli VA, Vanderveer PL, Dingivan CA, Mentzer RM Jr.

J Thorac Cardiovasc Surg. 1994 Jul;108(1):153-7.

PMID:
8028359
50.

Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.

Xue F, Yu H, Maurer LH, Memoli VA, Nutile-McMenemy N, Schuster MK, Bowden DW, Mao J, Noll WW.

Hum Mol Genet. 1994 Apr;3(4):635-8.

PMID:
7915165

Supplemental Content

Loading ...
Support Center